SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-022818
Filing Date
2023-02-02
Accepted
2023-02-02 17:00:00
Documents
13
Period of Report
2023-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d650071d8ka.htm   iXBRL 8-K/A 34848
2 EX-4.1 d650071dex41.htm EX-4.1 70583
  Complete submission text file 0001193125-23-022818.txt   258383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20230104.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20230104_lab.xml EX-101.LAB 19444
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20230104_pre.xml EX-101.PRE 12137
7 EXTRACTED XBRL INSTANCE DOCUMENT d650071d8ka_htm.xml XML 4297
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39122 | Film No.: 23581989
SIC: 2834 Pharmaceutical Preparations